PRIALT is a Intrathecal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Tersera Therapeutics Llc. The primary component is Ziconotide Acetate.
Product ID | 70720-723_3d41566d-29f2-4d31-9287-5f83a43df821 |
NDC | 70720-723 |
Product Type | Human Prescription Drug |
Proprietary Name | PRIALT |
Generic Name | Ziconotide Acetate |
Dosage Form | Injection, Solution |
Route of Administration | INTRATHECAL |
Marketing Start Date | 2018-10-15 |
Marketing Category | NDA / NDA |
Application Number | NDA021060 |
Labeler Name | TerSera Therapeutics LLC |
Substance Name | ZICONOTIDE ACETATE |
Active Ingredient Strength | 25 ug/mL |
Pharm Classes | N-Calcium Channel Receptor Antagonists [MoA],N-type Calcium Channel Antagonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2019-08-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021060 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-08-15 |
Ingredient | Strength |
---|---|
ZICONOTIDE ACETATE | 25 ug/mL |
SPL SET ID: | b025d8ed-937d-4597-9ad1-0b2f6e0ee5b1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
18860-720 | Prialt | ziconotide |
18860-722 | Prialt | ziconotide |
18860-723 | Prialt | ziconotide |
70720-720 | PRIALT | ziconotide acetate |
70720-722 | PRIALT | ziconotide acetate |
70720-723 | PRIALT | ziconotide acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PRIALT 75909746 2806847 Live/Registered |
TERSERA THERAPEUTICS LLC 2000-02-04 |